baber/WOPTO huggingface dataset:
Patent CA-2492821-A1 (CA)
Inventor: DEL RIO CARBAJO MARCOS
IPC: E04C2/24
Filed: 2002-09-17
Abstract: The invention relates to a sandwich-type panel of the type which consist of different successive layers and which comprise, by way of an outer face and/or counter face, a film of a transparent acrylic polymer to which an insoluble or slightly-soluble transparent thermoplastic has been added to the organic solvents. According to the invention, the surface films on the face and counter face have similar thermal expansion coefficients and a similar moisture absorption coefficient and basic weight. The invention is suitable for use in construction.
Patent CA-2493527-A1 (CA)
Title: Configuration for monitoring the state of health of a person
Inventor: CARLSON SVEN-ERIK
IPC: A61B5/332
Filed: 2003-08-28
Abstract: For the acquisition and/or monitoring of medically relevant data, in particular of the state of the cardiovascular system, of blood properties as well as electrocardiographic data of a person, for example with cardiovascul ar disorders or disorders of other organs, a configuration is proposed, which comprises: at least one measuring sensor (3, 3') for the acquisition of the circulatory state of the person (1); at least one electrode configuration (2 ) for the continuous registration and monitoring of the electrocardiographic data of the person; and an ECG measuring system (2), respectively electrodes , for the registration of an ECG in a chest belt (4), as well as additionally an evaluation unit for the detection of irregularities of the data acquired by the measuring sensor or the ECG measuring system; a sending and receiving device (5) for voice and/or data in order to address a third party (9) and t o transmit data to this third party; as well as - a positioning system, by mea ns of which the location of the person is transmitted to the third party.</SDOA B>
Patent CA-2493564-A1 (CA)
Inventor: WONG-STAAL FLOSSIE
IPC: C12N15/09
Filed: 2003-07-23
Abstract: The present invention relates to methods and compositions for the elucidation of gene function and the identification of novel genes. Specifically, the present invention relates to methods and compositions for improved functional genomic screening, functional inactivation of specific essential or non-essential genes, and identification of genes that are modulated in response to specific stimuli or encode recognizable phenotypic traits. In particular, the compositions of the present invention include, but are not limited to, expression cassettes comprising a novel dual promoter transcription system, that utilizes modified promoters, preferably containing complementary termination sequences, positioned across a coding sequence and in opposite orientation to each other. In addition, the present invention includes libraries comprising the expression cassettes of the invention, including vectors for transforming cells, such as replication-deficient retroviral vectors. The invention also includes methods for the production and screening of dsRNA/siRNA libraries, as well as therapeutic uses for the siRNAs expressed in accordance with the invention.
Patent CA-2494546-A1 (CA)
Title: Substituted glycine derivatives for use as medicaments
Inventor: BRYANS JUSTIN STEPHEN
IPC: C07C229/14
Filed: 2003-08-04
Abstract: The compounds of formula (I) are substituted glycine derivatives useful in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, arthritis, neuropathological disorders, sleep disorders, visceral pain disorders and gastrointestinal disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included.  Formula (I) wherein R' is hydroxycarbonyl, a carboxylic acid biostere or prodrug thereof; R3, R3a, R2 and R2a are independently selected from H, C1-C6 alkyl, and Cl-C6 alkoxy Cl-C6 alkyl.
Patent CA-2494883-A1 (CA)
Title: Apparatus and method for issuing documents of value
Inventor: STOUTENBURG EARNEY
IPC: G07F7/00
Filed: 1997-10-02
Abstract: An apparatus and method for issuing documents of value includes a compartment for receiving substrates on which information associated with a document of value is printed, a code reader which reads codes uniquely associated with each substrate from the substrates, a printer that prints information on the substrates, and a control terminal for controlling the code reader and printer, which is configured for communication with the code reader and for detection and recordation of the codes uniquely associated with each substrate. The control terminal detects and records deviations from in expected order of the codes uniquely associated with the substrates upon the substrates being received. The control terminal is also a print access controller permitting physical access to a portion of the printer upon receipt of an access code. A further aspect of the control terminal includes connecting with a system for modification of a portion of the apparatus.
Patent CA-2496724-A1 (CA)
Title: Catalyseur de reformage electroniquement conducteur pour pile a combustible, et son procede de realisation
Inventor: STEINFORT MARC
IPC: H01M8/06
Filed: 2003-08-20
Abstract: La présente invention concerne un catalyseur de reformage électroniquement conducteur destiné à une pile à combustible, notamment à une pile à combustible à carbonate en fusion, contenant des particules d'un matériau substrat (6) qui absorbe l'eau, et des particules d'un matériau catalytique (7) qui se trouve sur le matériau substrat (6). Selon l'invention, le matériau substrat (6) est intrinsèquement électroniquement conducteur. La conductivité électrique spécifique du catalyseur de reformage (4) dépasse de préférence 1 S/cm dans les conditions de fonctionnement.
Patent CA-2497437-A1 (CA)
Inventor: CACIAGLI FRANCESCO
IPC: A61K31/708
Filed: 2003-09-03
Abstract: Methods and compositions for preventing apoptosis are described. The method involves administering an effective amount of a purine nucleoside to a cell or an animal in need thereof. The methods are useful in treating diseases of th e nervous system including neurodegenerative diseases, stroke or spinal cord injuries.
Patent CA-2498436-A1 (CA)
Inventor: SUTCLIFFE JOHN
IPC: G06Q10/06
Filed: 2003-09-19
Abstract: An enterprise business planning system includes a server to an application server to execute an enterprise planning activity in accordance with a model that defines a set of enterprise users. The system further includes an extension manager to selectively deploy software extensions to the enterprise users in accordance with the model. The model may, for example, define roles for the enterprise users, and the extension manager selectively deploys the software extensions to the enterprise users based on the roles assigned to the enterprise users. As another example, enterprise model may comprises a multi-level hierarchy of related nodes, and associates the enterprise users with the nodes. The extension manager may selectively deploy the software extensions to the enterprise users based on the levels of respective nodes associated with the enterprise users.
Patent CA-2499376-A1 (CA)
Inventor: BARFKNECHT ROBERT J
IPC: F02B37/013
Filed: 2003-08-25
Abstract: An improved combustion air charger, such as a turbocharger or a supercharger, includes a housing (10) having a rotary shaft (18) journalled therein. At least one compressor wheel (20,22) is located on the shaft (18). The housing (10) includes an ambient inlet (30) as well as a compressed air outlet (32) and a heat exchanger (36) is located between at least one of the compressor wheels (20) and the outlet (32) and is arranged so that air flow through the heat exchanger (36) is generally in the radially inward direction.
Patent CA-2501571-A1 (CA)
Title: Tight focusing method and system
Inventor: EYTAN ORI
IPC: G11B7/125
Filed: 2003-10-07
Abstract: A method and system are presented for use in recording/reading data from an array of data units within a three-dimensional storage medium. Exciting radiation is provided in the form of first and second light beams of first and second different wavelengths, respectively. The first and second light beams are concurrently directed and focusing onto desirably distanced from each other sites in the medium and excited light of a third wavelength coming from the excited site is collected to form an excited light beam to be directed towards a detector assembly, while correcting for chromatic and spherical aberrations of the light focusing and collection. This focusing/collection is sequentially repeated for successive sites in the medium with varying depth of focus.
Patent CA-2502229-A1 (CA)
Title: Intravenous fluid delivery set
Inventor: FLAMENT-GARCIA MARY JANE
IPC: A61L29/04
Filed: 2003-10-03
Abstract: A flexible tubing for an intravenous fluid delivery set including an elongat e tubing member formed of aliphatic polyether polyurethane. The set may includ e connectors to a container and an intravenous needle, and additional connecto rs for components placed in line with the tubing, with hollow posts on the connectors, with the tubing ends adapted to friction fit over the posts. The posts may have outer diameters which are tapered from a first diameter to a second diameter, where the inner diameter of the tubing ends are less than t he second diameter. A method of delivering therapeutic fluid is also shown including providing the delivery set, providing a flow path by forcing tubin g ends over connector posts in an in-line arrangement, and then controlling th e flow of the therapeutic fluid between the container and the intravenous need le through the fluid flow path.
Patent CA-2505197-A1 (CA)
Inventor: HUBER JOCHEN
IPC: C12N5/06
Filed: 2003-11-05
Abstract: L'invention concerne un mammifère transformé transitoire utile comme modèle animal d'insuffisance cardiaque.
Patent CA-2506247-A1 (CA)
Title: Novel aldolase, and method for producing optically active ihog and monatin
Inventor: WATANABE KUNIHIKO
IPC: A23L27/30
Filed: 2005-05-25
Abstract: A method for producing optically active IHOG useful for the production of monatin, a method for producing optically active monatin, and aldolase used for the methods are provided. 4-(Indole-3-ylmethyl)-4-hydroxy-2-oxoglutaric acid with high optical purity which is useful as an intermediate in the synthesis of optically active monatin may be synthesized from indole pyruvic acid and pyruvic acid (or oxaloacetic acid).
Patent CA-2507149-A1 (CA)
Inventor: ADAMS MICHAEL R
IPC: F15B15/22
Filed: 2005-05-12
Abstract: A pneumatic cylinder having a cushioning valve assembly. A tubular body is capped by a pair of cylinder heads. A hollow cylinder rod having a piston assembly and cushioning valve assembly is seated within the tubular body for reciprocating action therein. The piston assembly is formed of a piston having a bore passing longitudinally therethrough and a cylindrical collar. The collar is mounted about the outside of one end of the hollow cylinder rod and the piston caps the end. The cushioning valve assembly comprises an elongated rod having a cushion piston at one end and a head at the other and is seated within the bore of the piston, such that the cushion piston is fitted within the interior of the hollow cylinder rod.
Patent CA-2507603-A1 (CA)
Title: Spinning plate
Inventor: AHM KLAUS
IPC: D04H3/153
Filed: 2003-11-26
Abstract: The invention relates to a spinning plate for the production of melt-spun fibers in order to produce geotextiles.
Patent CA-2510512-A1 (CA)
Inventor: ZBORIL JOSEF
IPC: C22C38/32
Filed: 2005-06-22
Abstract: A steel composition for the production of railway and tram crossing point frog castings is disclosed which includes iron with, by weight, 0.15 to 0.2% of carbon, 1 - 1.8% of manganese, 1 - 1.6% of silicone, 1.5 - 2.5% of chrome, 2.3 - 3.5% of nickel, 0.4- 0.7% of molybdenum and 0.0025 - 0.005% of boron. The composition has a higher wear and tear resistance and longer service life.
Patent CA-2511054-A1 (CA)
Title: System and method for managing informational objects on mobile devices
Inventor: ROBERTSON IAN M
IPC: H04M1/72469
Filed: 2005-06-28
Abstract: A system and method for managing informational objects on a mobile device. A user-selectable option is displayed to a user of the mobile device. The option is associated with an action to be performed on informational objects sharing at least one specified characteristic (e.g., storing all e-mail messages that are part of the same thread in a folder, generating a distribution list of contacts belonging to a specified group). After the user has selected the option, the application identifies informational objects having the at least one specified characteristic and performs the action on the identified objects.
Patent CA-2511146-A1 (CA)
Inventor: JIN XIN
IPC: H04B1/48
Filed: 2005-06-29
Abstract: In one illustrative example, a mobile station includes a wireless transceiver; a user interface including a Push-To-Talk (PTT) switch for initiating a PTT voice communication and a microphone for receiving voice input signals; one or more processors; and memory (e.g. a First-In-First-Out (FIFO) buffer memory) coupled to the one or more processors. The one or more processors are operative to identify a user actuation of the PTT switch and, in response, save digital voice data corresponding to voice input signals in the memory; cause a request for the PTT voice communication to be made through a wireless network; identify that a floor grant has been received through the wireless network in response to the request; and after identifying the floor grant, cause the digital voice data from the memory to be retrieved and transmitted to the wireless network for the PTT voice communication. Advantageously, the saving of the digital voice data in the memory is performed at least in part during a delay time period between the user actuation of the PTT switch and the identifying of the floor grant.
Patent CA-2514643-A1 (CA)
Title: Light probe for ultraviolet light activated gene transduction
Inventor: FOSTER THOMAS H
IPC: A61K41/00
Filed: 2004-01-30
Abstract: In accordance with the present invention, a light probe is provided for treating a patient through the use of ultraviolet light activated gene therapy. Embodiments of the present invention include a light probe structure for the utilization of light activated gene therapy to repair and/or rebuild damaged cartilage or a component of a functional spinal unit (FSU) by introducing a desired gene into a patient's tissue.
Patent CA-2515407-A1 (CA)
Title: Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
Inventor: OVOKAITYS TODD
IPC: A61K41/00
Filed: 2004-02-09
Abstract: A method for improving the bioavailability of a bioactive substance includes subjecting the bioactive substance to laser radiation. The laser radiation modifies the bioactive substance to thereby modify reactions relating thereto in the body. The method enables reductions in inflammation associated with autoimmune diseases, modification of reaction by-products in the body, increased homogenization and flattening of molecular shape and improved methylation. The improved methylation can be utilized to reduce homocysteine blood levels, and to reduce anxiety, depression, paranoia, hostility, somatization (perception of bodily distress) and obsessive-compulsive symptoms. Enhanced nitric oxide generation from modified L~arginine can be used to reduce systolic and diastolic blood pressure, lower total and LDL  cholesterol levels, and improve the ratio of total to HDL cholesterol.  Increased depth of penetration of sparse constructive nodes of laser radiation may increase the range of photodynamic therapy applications and a wide range of in vitro and in vivo modifications of molecular shape and activity. Laser acoustic resonance can be utilized to increase the homogeneity of crystals, or favor the generation of novel or preferred crystalline forms.
Patent CA-2516900-A1 (CA)
Title: Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
Inventor: HAWLEY MICHAEL
IPC: A61K31/403
Filed: 2004-02-23
Abstract: The present invention relates to polymorphs of the 3-pyrrole substituted 2-indolinone compound 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide.
Patent CA-2518207-A1 (CA)
Inventor: FUKAYA KOHEI
IPC: A61F2/91
Filed: 2004-03-05
Abstract: A stent capable of further reducing the frequency of occurrence of repeated stenosis (restenosis) in a conventional stent, wherein a structure for cutting an organism tissue is disposed on the outer surface of a stent body. Since the structure is expanded while cutting body structures such as blood vessel when the stent is expanded in the radial outer direction and then indwelled, the restenosis can be suppressed by reducing stress and disorder damage to the body structures such as the blood vessel. Also the effect of the structure can be more increased by applying chemicals thereto.
Patent CA-2519001-A1 (CA)
Inventor: AZIZI SOUFIANE
IPC: G06F16/903
Filed: 2005-09-13
Abstract: A data agnostic business intelligence query system and method are provided. The system comprises a query set component for defining data to be retrieved fro m a database, and a query result definition component for describing the dimensional structure of a result set for the data to be retrieved. The method comprising the step s of translating the gesture into a data agnostic business intelligence query, divide data agnostic business intelligence query into sub-queries grouped into data source query types, an d sending each sub-query to a data source query engine based upon its data source quer y type.
Patent CA-2519133-A1 (CA)
Inventor: REID LAWRENCE C
IPC: A45F3/12
Filed: 2004-03-12
Abstract: L'invention concerne un système de suspension de sac à dos comprenant un balancier relié pivotant au sac à dos. Un premier appui de hanche présente une première extrémité reliée à une première extrémité du balancier et une seconde extrémité opposée à la première. Un second appui de hanche présente une première extrémité reliée à une seconde extrémité du balancier et une seconde extrémité opposée à la première. Une ceinture est fixée à la seconde extrémité du premier appui de hanche et à la seconde extrémité du second appui de hanche. Ces deux appuis distribuent la charge du sac à dos entre les hanches gauche et droite. L'invention concerne également un sac à dos incorporant le système de suspension considéré.
Patent CA-2523174-A1 (CA)
Title: Method of managing communication buffers employing an application framework for a plurality of communication layers and node employing the same
Inventor: NAEVE MARCO
IPC: H04L29/06
Filed: 2005-10-11
Abstract: A method of network communication includes employing a communication network protocol stack having a plurality of independent communication layers providing a plurality of different corresponding services. A buffer manager is employed for a plurality of communication buffers. The buffer manager is independent of the independent communication layers. An applicati on framework provides asynchronous communications among the buffer manager and the independent communication layers. For a plurality of pairs of the buffer manager and one of the independent communication layers and for a plurality of pairs of the independent communication layers, the method provides subscribing by the buffer manager and by the independent communication layers to a plurality of events through the application framework and publishing by the buffer manager and b y the independent communication layers a plurality of corresponding events through the application framework.
Patent CA-2525512-A1 (CA)
Title: Pseudo-distillation method for purifying a dry cleaning solvent
Inventor: SCHEPER WILLIAM MICHAEL
IPC: D06F43/08
Filed: 2004-06-06
Abstract: Pseudo-distillation, steady-state method for purifying dry cleaning solvents containing laundry soils and other contaminants.
Patent CA-2526430-A1 (CA)
Title: Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
Inventor: MICHAELIDES MICHAEL R
IPC: C07D413/02
Filed: 2004-05-21
Abstract: Compounds having the formula (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Patent CA-2527559-A1 (CA)
Inventor: NAKAISHI MASAKI
IPC: H02M7/48
Filed: 2004-05-25
Abstract: At least one of a start failure detector (31), a temperature failure detector (32), and a voltage failure detector (33) has a holding inhibit circuit for inhibiting holding of a detection state when one of the failure detectors has detected a failure, so that a current failure detector (34) does not detect the input current failure caused by the oscillation stop by the failure detection. Accordingly, after each failure is corrected, automatic recovery is easily performed without generating in the current failure detector (34) the oscillation stop due to each of the failure detections. Moreover, since a power source failure detector (30) is constituted by an analog circuit, it can be obtained at a low cost and its monitoring level can easily be modified.  Furthermore, it is possible to modify the monitoring level only for the temperature failure of the IGBT element (7).
Patent CA-2527881-A1 (CA)
Title: Uses of melanocortin-3 receptor (mc3r) agonist peptides
Inventor: HSIUNG HANSEN MAXWELL
IPC: A61P3/04
Filed: 2004-06-17
Abstract: The present invention provides methods of treating metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, methods of inducing weight loss and increasing muscle mass in a patient, by administration of MC3R agonist peptides.  Furthermore, the present invention provides the use of an MC3R agonist peptide for the manufacture of a medicament for the treatment of metabolic disorders, including, for example, obesity, diabetes mellitus, cachexia, sarcopenia, and cardiovascular disorders, inducing weight loss and increasing muscle mass in a patient.
Patent CA-2529608-A1 (CA)
Inventor: BERNAD DENES
IPC: C02F1/30
Filed: 2005-12-08
Abstract: The present invention provides a system that utilizes microwave heating to sterilize contaminated effluent. The system sterilizes the contaminated effluent by heating it to a minimum temperature for a minimum duration under pressure, and then discharging it to a sanitary drain as sterilized effluent. The process maximizes energy efficiency by using a heat exchanger to raise the temperature of the contaminated effluent with heat drawn from the sterilized effluent of the previous batch.  All solids and particles originally present in the contaminated effluent pass through the system and are discharged as part of the sterilized effluent.
Patent CA-2532722-A1 (CA)
Title: Cystatin sn (cst1) and other markers for detection of gastric cancer
Inventor: HOLYOAKE ANDREW JOHN
IPC: C12Q1/68
Filed: 2004-07-16
Abstract: Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the GTM gene family can be over-expressed in gastric tumor tissue and other tumor tissue, and thus can be used as markers for gastric and other types of cancer. GTM  proteins can be released from cancer cells, and can reach sufficiently high concentrations in the serum and/or other fluids to permit their detection.  Thus, methods and test kits for detection and quantification of GTM can provide a valuable tool for diagnosis of gastric cancer.